Rankings
▼
Calendar
ACRS FY 2017 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$407M
FY 2017 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$2M
Gross Profit
$476,000
28.3% margin
Operating Income
-$72M
-4303.2% margin
Net Income
-$69M
-4071.5% margin
EPS (Diluted)
$-2.44
Cash Flow
Operating Cash Flow
-$55M
Free Cash Flow
-$56M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$244M
Total Liabilities
$18M
Stockholders' Equity
$225M
Cash & Equivalents
$209M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$476,000
-$120,000
+496.7%
Operating Income
-$72M
-$49M
-49.1%
Net Income
-$69M
-$48M
-42.5%
← Q4 2016
All Quarters
Q1 2017 →